Ambow Files its Annual Report on Form 20-F for Fiscal Year 2023

Stock Information for Eagle Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Eagle Pharmaceuticals Inc.

Ambow Education Announces Second Half and Full-Year 2024 Financial Results
Ambow Files Annual Report on Form 20-F for Fiscal Year 2024
Argus Research Initiates Equity Report Coverage on Ambow Education Holding Ltd. (NYSEAM: AMBO)
Ambow Education Announces Second Quarter and First Half of 2024 Financial Results
Ambow Education Secures $1.3 Million International Licensing Deal for HybriU
Ambow Education Announces Second Half and Full-Year 2023 Financial Results
Ambow Education Showcases Cutting-edge HybriU Technology at Open House
Ambow Education to Host Open House at San Diego Campus from April 14-16, 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.